Intelligent Bio Solutions Inc.
INBS
$0.66
-$0.01-1.58%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.27% | -1.90% | 3.87% | 23.21% | 55.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.27% | -1.90% | 3.87% | 23.21% | 55.28% |
| Cost of Revenue | 13.70% | 7.09% | -44.19% | -24.60% | 10.30% |
| Gross Profit | -7.90% | -12.54% | 161.81% | 204.22% | 175.56% |
| SG&A Expenses | 9.65% | -4.05% | -2.04% | 4.26% | -3.13% |
| Depreciation & Amortization | 1.41% | 0.55% | 9.73% | 3.64% | -6.30% |
| Other Operating Expenses | -100.48% | -92.30% | -32.39% | -0.38% | 17.75% |
| Total Operating Expenses | 0.43% | 0.61% | 2.72% | 14.26% | 15.87% |
| Operating Income | 0.43% | -1.38% | -2.40% | -11.98% | -7.57% |
| Income Before Tax | -4.32% | -4.06% | -2.29% | 20.09% | 12.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.32% | -4.06% | -2.29% | 20.09% | 12.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 7.76% | 5.87% | -2.25% | 6.38% | 5.25% |
| Net Income | -4.31% | -4.06% | -2.31% | 20.16% | 12.08% |
| EBIT | 0.43% | -1.38% | -2.40% | -11.98% | -7.57% |
| EBITDA | 0.66% | -1.56% | -1.59% | -12.82% | -7.41% |
| EPS Basic | 66.31% | 87.68% | 93.81% | 96.73% | 95.42% |
| Normalized Basic EPS | 67.52% | 87.87% | 93.72% | 94.42% | 92.35% |
| EPS Diluted | 66.32% | 87.68% | 93.81% | 96.73% | 95.42% |
| Normalized Diluted EPS | 67.52% | 87.87% | 93.72% | 94.42% | 92.35% |
| Average Basic Shares Outstanding | 161.64% | 237.10% | 415.49% | 904.06% | 2,014.57% |
| Average Diluted Shares Outstanding | 161.64% | 237.10% | 415.49% | 904.06% | 2,014.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |